Targeted drug aims to clear hidden leukemia before transplant
NCT ID NCT03610438
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study tests whether the targeted drug inotuzumab ozogamicin can eliminate minimal residual disease (MRD) in adults with B-cell acute lymphoblastic leukemia (ALL) before they receive a stem cell transplant. Participants have either Philadelphia chromosome-positive or -negative ALL with detectable MRD after prior therapy. The goal is to see if the drug can make MRD undetectable, which may lead to better transplant outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- inotuzumab ozogamicin, an antibody-drug conjugate that targets cancer cells
- What this could lead to
- If successful, this approach could help more patients achieve a cancer-free state before a stem cell transplant, potentially improving long-term outcomes.
- What could go wrong
- This is an early-phase study with a small number of participants, so results may not apply broadly. The drug can cause serious side effects like liver damage and low blood cell counts.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ao Di Rilievo Nazionale Antonio Cardarelli - Napoli - Uoc Ematologia Con Trapianto Di Midollo
Naples, Italy
-
Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo
Palermo, Italy
-
Aou "San Giovanni Di Dio E Ruggi D'Aragona" - Salerno - Uoc Ematologia E Trapianti Di Cellule Staminali Emopoietiche
Salerno, Italy
-
Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia 2
Torino, Italy
-
Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia
Bologna, Italy
-
Aou Integrata Di Verona, Policlinico G.B. Rossi - Uoc Ematologia
Verona, Italy
-
Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona- Sod Clinica Ematologica
Ancona, Italy
-
Aou Senese - Uoc Ematologia E Trapianti
Siena, Italy
-
Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia
Ascoli Piceno, Italy
-
As Dell'Alto Adige, Ospedale Centrale Di Bolzano - Ematologia E Centro Trapianto Midollo Osseo
Bolzano, Italy
-
Asl Lecce, Ospedale 'V. Fazzi' - Uo Ematologia
Lecce, Italy
-
Asl Pescara, Presidio Ospedaliero 'Spirito Santo' - Uoc Ematologia Clinica
Pescara, Italy
-
Asl Roma 2, Ospedale S. Eugenio- Ospedale S.Eugenio - Uoc Ematologia
Roma, Italy
-
Aso S. Croce E Carle - Cuneo - Sc Ematologia
Cuneo, Italy
-
Asst Degli Spedali Civili Di Brescia - Uo Ematologia
Brescia, Italy
-
Asst Grande Ospedale Metropolitano Niguarda - Milano - Sc Ematologia
Milan, Italy
-
Asst Papa Giovanni Xxiii - Ospedale Di Bergamo - Sc Ematologia
Bergamo, Italy
-
Asui Di Udine - Presidio Ospedaliero "Santa Maria Della Misericordia" - Clinica Ematologica
Udine, Italy
-
Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia
Mestre, Italy
-
Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia
Vicenza, Italy
-
Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia
Rimini, Italy
-
Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia
San Giovanni Rotondo, Italy
-
Fondazione Ircss Policlinico San Matteo - Pavia - Uo Ematologia
Pavia, Italy
-
Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Po E. Morelli - Reggio Calabria - Uoc Ematologia
Reggio Calabria, Italy
-
I.R.S.T. Srl Irccs - Meldola - Sc Oncologia Medica
Meldola, Italy
-
Irccs Aou San Martino - Genova - Uo Clinica Ematologica
Genova, Italy
-
Irccs Ospedale S. Raffaele - Milano - Uo Oncoematologia
Milan, Italy
-
Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia
Milan, Italy
-
Unità Operativa Di Ematologia - Presidio Ospedaliero Di Treviso - Azienda Ulss N.2 Marca Trevigiana
Treviso, Italy
-
Università Degli Studi Di Roma "Sapienza" - Dipartimento Di Medicina Traslazionale E Di Precisione - U.O.C. Ematologia
Roma, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Supercharged immune cells take aim at cancer and viruses in one shot
- Double-Pronged immune cells take aim at stubborn blood cancers
- Engineered immune cells take aim at Tough-to-Treat blood cancers
- Combination therapy aims to keep leukemia in check after transplant
- Dual-Pronged CAR T-Cell therapy takes aim at Hard-to-Treat leukemia
- Engineered immune cells take aim at leukemia that evades standard therapy